TNFRSF8 and classic Hodgkin lymphoma: Subsequently, two parallel phase 1/2 studies of CD30-CAR T in patients with R/R CD30+ lymphoma were conducted, enrolling 41 adult patients with heavily pretreated cHL (NCT02690545, NCT02917083) (149).